Correlations between histological type, clinical behaviour, and prognosis in thymoma

Ricci, C; Rendina, E A; Pescarmona, E O; Venuta, F; Di Tolla, R; Ruco, L P; Baroni, C D
June 1989
Thorax;Jun1989, Vol. 44 Issue 6, p455
Academic Journal
No abstract available.


Related Articles

  • Histologic Types of Thymoma Associated with Pure Red Cell Aplasia: A Study of Five Cases... Kuo, Tseng-tong; Shih, Lee-Yung // International Journal of Surgical Pathology;Jan2001, Vol. 9 Issue 1, p29 

    Presents a study on five thymomas associated with pure red cell aplasia (PRCA) showing various histologic types, including an unusual composite thymoma. Clinical features; Pathological features of a thymic tumor; Microscopic appearance of a composite thymoma.

  • Clinicopathological analysis of thymic malignancies with a consistent retrospective database in a single institution: from Tokyo Metropolitan Cancer Center. Yusuke Okuma; Yukio Hosomi; Kageaki Watanabe; Yuko Yamada; Hirotoshi Horio; Yoshiharu Maeda; Tatsuru Okamura; Tsunekazu Hishima // BMC Cancer;2014, Vol. 14 Issue 1, p287 

    Background Thymic epithelial tumors (TETs), which comprise thymoma and thymic carcinoma, are rare cancers with specific morphological and clinical features. Their clinical characteristics and outcomes have gradually been clarified by assessing large-scale, retrospective data obtained with...

  • Expression of P120 catenin, Kaiso, and metastasis tumor antigen-2 in thymomas. Wang, Yan; Li, Li; Li, Qingchang; Xie, Chengyao; Wang, EnDi; Wang, Enhua // Tumor Biology;Dec2012, Vol. 33 Issue 6, p1871 

    Thymomas of the same histological subtype sometimes manifest different biological behaviors. Metastasis Tumor Antigen-2 (MTA2) is targeted by the transcriptional repressor Kaiso, the distribution which is thought to be modulated by p120catenin (p120ctn). It is currently unclear if expression of...

  • The role of histology in predicting recurrence of type A thymomas: a clinicopathologic correlation of 23 cases. Vladislav, I Tudor; Gökmen-Polar, Yesim; Kesler, Kenneth A; Loehrer, Patrick J; Badve, Sunil // Modern Pathology;Aug2013, Vol. 26 Issue 8, p1059 

    No abstract available.

  • Thymoma and inter-relationships between clinical variables: a multicentre study in 537 patients†. Filosso, Pier Luigi; Venuta, Federico; Oliaro, Alberto; Ruffini, Enrico; Rendina, Erino Angelo; Margaritora, Stefano; Casadio, Caterina; Terzi, Alberto; Rena, Ottavio; Lococo, Filippo; Guerrera, Francesco // European Journal of Cardio-Thoracic Surgery;Jun2014, Vol. 45 Issue 6, p1020 

    OBJECTIVES In thymomas, the roles of Masaoka-Koga stage, histology and the presence of myasthenia gravis (MG) have been considered fundamental for patient management and outcomes. In this study, we retrospectively evaluated several clinical variables, with the aim of outlining their...

  • Does the World Health Organization histological classification predict outcomes after thymomectomy? Results of a multicentre study on 750 patients. Guerrera, Francesco; Rendina, Erino Angelo; Venuta, Federico; Margaritora, Stefano; Ciccone, Anna Maria; Novellis, Pierluigi; Novero, Domenico; Anile, Marco; Bora, Giulia; Rena, Ottavio; Casadio, Caterina; Mussi, Alfredo; Evangelista, Andrea; Ruffini, Enrico; Lucchi, Marco; Filosso, Pier Luigi // European Journal of Cardio-Thoracic Surgery;Jul2015, Vol. 48 Issue 1, p48 

    OBJECTIVES: The World Health Organization (WHO) thymoma histological classification clinical value remains a controversy. In this study, we evaluated its prognostic significance in patients with thymoma treated with radical intent. METHODS: Six high-volume Italian Thoracic Surgery Institutions...

  • Association of clinical and pathological variables with survival in thymoma. Aydiner, Adnan; Toker, Alper; Sen, Fatma; Bicakci, Ercan; Saglam, Esra; Erus, Suat; Eralp, Yesim; Tas, Faruk; Oral, Ethem; Topuz, Erkan; Dilege, Sukru // Medical Oncology;Sep2012, Vol. 29 Issue 3, p2221 

    Our aim was to evaluate clinical and pathological features in prognosis of thymoma patients with particular emphasis on patients with myasthenia gravis (MG). From 1995 to 2010, 140 thymoma patients (women/men: 63/77) with a median age of 46 years (11-80 years) were admitted to our institution....

  • Prognosis and therapeutic response according to the world health organization histological classification in advanced thymoma. Tagawa, Tetsuzo; Kometani, Takuro; Yamazaki, Koji; Okamoto, Tatsuro; Wataya, Hiroshi; Seto, Takashi; Fukuyama, Seiichi; Osoegawa, Atsushi; Hirai, Fumihiko; Sugio, Kenji; Ichinose, Yukito // Surgery Today;Dec2011, Vol. 41 Issue 12, p1599 

    Purpose: The clinical efficacy of the World Health Organization (WHO) classification of thymoma has been reported to be a prognostic factor for patients with thymomas. This study focuses on the relationship between the therapeutic response and the WHO histological classification in patients with...

  • Slug overexpression is associated with poor prognosis in thymoma patients. TIANQIANG ZHANG; XU CHEN; XIUMEI CHU; YI SHEN; WENJIE JIAO; YUCHENG WEI; TONG QIU; GUANZHONG YAN; XIAOFEI WANG; LINHAO XU // Oncology Letters;Jan2016, Vol. 11 Issue 1, p306 

    Slug, a member of the Snail family of transcriptional factors, is a newly identified suppressive transcriptional factor of E-cadherin. The present study investigated the expression pattern of Slug in thymomas to evaluate its clinical significance. Immunohistochemistry was used to investigate the...

  • WHO types A and AB thymomas: not always benign. Jain, Rohit K; Mehta, Rutika J; Henley, John D; Kesler, Kenneth A; Loehrer, Patrick J; Badve, Sunil // Modern Pathology;Dec2010, Vol. 23 Issue 12, p1641 

    No abstract available.


Read the Article


Sign out of this library

Other Topics